NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 264 filers reported holding NOVOCURE LTD in Q2 2020. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $986,000 | -40.3% | 5,700 | -61.6% | 0.02% | -45.5% |
| Q3 2020 | $1,651,000 | +28.1% | 14,834 | -31.7% | 0.03% | +17.9% |
| Q2 2020 | $1,289,000 | +89.8% | 21,733 | +115.5% | 0.03% | +64.7% |
| Q1 2020 | $679,000 | +8.5% | 10,087 | +35.9% | 0.02% | +41.7% |
| Q4 2019 | $626,000 | +12.8% | 7,424 | 0.0% | 0.01% | +9.1% |
| Q3 2019 | $555,000 | – | 7,424 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $24,386,000 | 14.72% |
| HARTLINE INVESTMENT CORP/ | 335,191 | $58,001,000 | 8.32% |
| Deep Track Capital, LP | 1,341,300 | $93,220,000 | 6.13% |
| MORGAN JESS S & CO INC | 48,345 | $3,360,000 | 3.48% |
| Taylor Frigon Capital Management LLC | 68,908 | $4,789,000 | 2.49% |
| HighVista Strategies LLC | 28,007 | $1,946,000 | 1.18% |
| Private Harbour Investment Management & Counsel, LLC | 13,106 | $911,000 | 1.01% |
| Lloyd Park, LLC | 9,325 | $648,000 | 0.68% |
| Baillie Gifford | 9,116,230 | $633,578,000 | 0.65% |
| HAP Trading, LLC | 110,900 | $10,575,000 | 0.53% |